Cardiovascular Atherosclerosis CME Conference - May 2022 - San Diego, CA

Memo

Atherosclerotic cardiovascular disease is a common problem which may begin early in life and progress as a person ages. The atherosclerotic condition involves lipid deposition of the arterial wall, which involves the immune system, inflammatory mediators, and the endothelial system. Over time, if developing atherosclerosis is left untreated, it may be progressive and can result in several dangerous and life-threatening cardiovascular conditions including myocardial infarction, carotid artery disease and stroke, among others. While atherosclerosis can often be prevented through good lifestyle choices including proper diet and exercise, a number of therapeutic options are available for patients where lifestyle changes may not be enough. Over the past several years there has been a substantial increase of clinical trials specifically dedicated to the management and treatment of atherosclerosis and underlying risk factors. These studies have generated comprehensive data on a large number of randomized patients and have led to new indications for medical therapies. Clinicians need to be familiar with these evolving clinical diagnoses and novel therapeutic options for their patients. The Scripps Cardiovascular Atherosclerosis conference is designed to offer a comprehensive summary of these new treatment options as well as to promote clinical awareness regarding prudent lifestyle and dietary choices to improve patient outcomes. Date and Time: On Saturday May 21, 2022 at 7:00 AM - 5:00 PM Venue details: San Diego Marriott La Jolla, 4240 La Jolla Village Drive, San Diego, California, 92037, United States Prices:In-person Physicians (MD, DO, MBBS): USD 250.00,In-person RN, NP, PA, Other: USD 150.00,In-person Students, Residents, Fellows: USD 100.00,Virtual Physicians (MD, DO, MBBS): USD 275.00,Virtual RN, NP, PA, Other: USD 175.00,Virtual Students, Residents, Fellows: USD 125.00 Speakers: Matthew Budoff, MD, FACC, FAHA - The Lundquist Institute, Samantha Harris, MD - Scripps Whittier Diabetes Institute, Jeffrey Hsu, MD, MPH - Harbor-UCLA Medical Center, Luke Laffin, MD - Cleveland Clinic, Evan Muse, MD, PhD, MCTI, FACC, FAHA - Scripps Translational Science Institute, Douglas Triffon, MD, FACC, FNLA, FASE - Scripps Clinic, Michael Wilkinson, MD - UC San Diego Health